3645 results for «569»
3645 results
TAVI optimisation
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this series of slides to enhance your understanding of TAVI optimisation through selected studies for PCR Tokyo Valves 2024. Learn about the prognostic value of right ventricle dysfunction after TAVR, explore a risk model in dialysis patients following TAVR, and explore the impact of age...
Rapid-fire - Mitral TEER for complex situations
18 Feb 2024 – From PCR Tokyo Valves 2024
This series of rapid-fire submitted cases focuses on mitral TEER for complex situations. Learn about creative solutions to these situations such as clip inversion grasping, independent leaflet grasping with a CGA system, and more!
Rapid-fire - Outcome studies after valvular intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
This session of rapid-fire submitted cases focuses on outcome studies after valvular intervention. Learn about clinical impacts of cerebral micro-bleeds in patients undergoing TAVI, explore the long-term outcomes of Venus P valve for dysfunctional right ventricular outflow tract, and more!
Imaging for aortic valve disease
18 Feb 2024 – From PCR Tokyo Valves 2024
Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
